In our study, we showed that Bcl-2, which is associated with the emergence of androgen independence of prostate cancer [20, 21], is a target of miR-143 using bioinformatics analysis, which is further confirmed by luciferase assay. This evidence concerns the gene BCL2 and prostate carcinoma.